| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/07/2002 | WO2002009672A1 Liposomes containing a gelled aqueous internal phase |
| 02/07/2002 | WO2002009671A2 Microemulsion and micelle systems for solubilizing drugs |
| 02/07/2002 | WO2002009670A1 Liquid or semi-solid pharmaceutical excipient and pharmaceutical composition comprising the same |
| 02/07/2002 | WO2002009669A2 Apparatus and process to produce particles having a narrow size distribution and particles made thereby |
| 02/07/2002 | WO2002009668A2 Pulmonary administration of flint |
| 02/07/2002 | WO2002009667A2 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/07/2002 | WO2002009666A1 Pharmaceutical extemporary compositions |
| 02/07/2002 | WO2002009653A1 Adhesive cosmetic patches |
| 02/07/2002 | WO2002009647A2 Biological component comprising artificial membrane |
| 02/07/2002 | WO2002009637A2 Pharmaceutical compositions for the treatment of mucositis, stomatitis and behcet's syndrome |
| 02/07/2002 | WO2002009631A1 Vaginal delivery of bisphosphonates |
| 02/07/2002 | WO2001080824A3 Dual mechanism timed release dosage forms for low dose drugs |
| 02/07/2002 | WO2001074395A3 Amiodarone-containing parenteral solution |
| 02/07/2002 | WO2001074380A3 Medicament containing a tissue inhibitor of metalloproteinases-2 (timp-2) as an osteo-anabolically active substance |
| 02/07/2002 | WO2001070271A3 Acid-stable base compositions for preparing surfactant free topical compositions |
| 02/07/2002 | WO2001068060A3 Stabilised oversaturated transdermal therapeutical matrix systems |
| 02/07/2002 | WO2001064274A3 Metered dose inhaler |
| 02/07/2002 | WO2001062744A3 Substituted piperazine compounds |
| 02/07/2002 | WO2001060417A3 Radioactive therapeutic liposomes |
| 02/07/2002 | WO2001050866A3 Method and device for sanitation using bacteriophages |
| 02/07/2002 | WO2001049260A3 Y-ifn liquid-droplet aerosol and method |
| 02/07/2002 | WO2001040240A3 Mono- and disaccharide derivatives |
| 02/07/2002 | WO2001037803A3 Responsive polymeric hollow particles |
| 02/07/2002 | WO2001035953A3 Exercise and muscle enhancement formulations |
| 02/07/2002 | WO2001029233A3 Chimeric immunogenic compositions and nucleic acids encoding them |
| 02/07/2002 | WO2001017479B1 Methods and compositions for preventing and treating prostate disorders |
| 02/07/2002 | WO2000072883A9 Pharmaceutical transdermal compositions |
| 02/07/2002 | US20020016568 Microprocessor controlled ambulatory medical apparatus with hand held communication device |
| 02/07/2002 | US20020016518 Granulation by wet route with binder achieves needle shaped particles of given characteristics: low hygroscopicity, high specific surface, low bulk density, high compressability, low friability and relatively low particle size |
| 02/07/2002 | US20020016498 Jet streams of solvent impinge creating high turbulence at point of impact on chemical intermediates; eliminates need for high intensity milling |
| 02/07/2002 | US20020016452 Soaking wood pulp in sodium hydroxide to produce alkali cellulose which is reacted with propylene oxide, the product is dissolved in water, precipitated, neutralized with acetic acid, washed, dried and grinded; pharmaceutical excipients |
| 02/07/2002 | US20020016373 Adding to the fluoroether compound selected from evoflurane, enflurane, isoflurane, methoxyflurane and desflurane an effective stabilizing amount of a lewis acid inhibitor to prevent the degradation of fluoroether |
| 02/07/2002 | US20020016370 A therapeutically effective amount of exo-R-mecamylamine or salt, substantially free of exo-S-mecamylamine in combination with a carrier; useful for treating substance addiction |
| 02/07/2002 | US20020016320 Inhibiting beta-secretase enzyme activity and A beta peptide production. |
| 02/07/2002 | US20020016317 From ester interchange of monounsaturated fatty acid esters with sterols; food additives |
| 02/07/2002 | US20020016315 Metered unit dose comprising 40 mu g or less of budesonide is disclosed as well as a formulation thereof and the use for the treatment of conditions in the nose, especially rhinitis. |
| 02/07/2002 | US20020016302 Idarubicin with encapsulation degree higher than 94%. |
| 02/07/2002 | US20020016295 Keratinocyte growth factor-2 formulations |
| 02/07/2002 | US20020016292 Pharmaceutical compositions containing cyclosporins |
| 02/07/2002 | US20020016290 At least 50 weight percent of the cyclosporin present in the dispersion is of particles less than about 1 mu m, said cyclosporin being amorphous. |
| 02/07/2002 | US20020015740 Administering nitrogen oxide mimetic |
| 02/07/2002 | US20020015737 Proteins deposited onto sparingly soluble biocompatible particles for controlled protein release into a biological environment from a polymer matrix |
| 02/07/2002 | US20020015736 Anti-inflammatory pharmaceutical formulations |
| 02/07/2002 | US20020015735 Oral administering |
| 02/07/2002 | US20020015734 Mixture of protein and heat sensitive polymer |
| 02/07/2002 | US20020015733 Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates |
| 02/07/2002 | US20020015732 Formulation of a 5 alpha reductase inhibitor for oral administrtion, and a preparation process and use thereof |
| 02/07/2002 | US20020015731 Hydrogel-Driven Drug Dosage Form |
| 02/07/2002 | US20020015730 Pharmaceutical formulations and method for making |
| 02/07/2002 | US20020015729 Colonic delivery of weak acid drugs |
| 02/07/2002 | US20020015728 Method and form of a drug delivery device, such as encapsulating a toxic core within a non-toxic region in an oral dosage form |
| 02/07/2002 | US20020015726 Dressings and bandages comprising same |
| 02/07/2002 | US20020015721 Dispersion containing nonionic surfactants |
| 02/07/2002 | US20020015720 Polymer blends as biodegradable matrices for preparing biocomposites |
| 02/07/2002 | US20020015715 Inducing interferon and tumor necrosis factor locally in the skin or mucous memebranes by applying 4-amino-2-ethoxymethyl-alpha,alpha-di methyl-1H-imidazo(4,5-c)quinoline-1-ethanol, silica sol, triacetin and propylene glycol |
| 02/07/2002 | US20020015714 Composition comprising a hydrophilic component and a combination of a volatile compound and a phenylated silicone oil, and use thereof |
| 02/07/2002 | US20020015713 An amine containing compound such as the antidepressant dioxepin or the muscle relaxant guaifenesin and carriers |
| 02/07/2002 | US20020015712 Temperature controlled solute delivery system |
| 02/07/2002 | US20020015709 Administration of leptin |
| 02/07/2002 | US20020015687 Method for the anhydrous loading of nicotine onto ion exchange resins |
| 02/07/2002 | US20020014307 Plaster agent and method of preparing same |
| 02/07/2002 | US20020014182 For use in electrical devices, magnetic devices, optical devices, biomedical devices, and electrochemical devices |
| 02/07/2002 | DE10036017A1 Immunostimulation by administration of purple cornflower preparation, using rectal syringe for direct injection into the lower intestines |
| 02/07/2002 | DE10035620A1 Intraokulare Infusionslösung The intraocular infusion solution |
| 02/07/2002 | DE10035088A1 Vitamin-C-Präparat und Verfahren zu dessen Herstellung Vitamin C preparation and process for its preparation |
| 02/07/2002 | CA2455170A1 Charged phospholipid compositions and methods for their use |
| 02/07/2002 | CA2418107A1 Method for reducing or eliminating smoking |
| 02/07/2002 | CA2417840A1 Bimodal emulsions of taxanes and butyrate polyalcohol esters |
| 02/07/2002 | CA2417788A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field |
| 02/07/2002 | CA2417533A1 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 02/07/2002 | CA2417489A1 Use of indole derivatives for the manufacture of a medicament for reducing intracular pressure |
| 02/07/2002 | CA2416978A1 Use of an aldehyde 5-oxo-1,2,4-triazine hydrazide for the treatment of cancer |
| 02/07/2002 | CA2416694A1 Paroxetine tablets and capsules |
| 02/07/2002 | CA2416122A1 Vaginal delivery of bisphosphonates |
| 02/07/2002 | CA2407596A1 Methods for treating burns on mammalian skin to reduce the risk of infection and to minimize fluid loss |
| 02/07/2002 | CA2388550A1 Dispersions for formulating slightly or poorly soluble active ingredients |
| 02/06/2002 | EP1177813A1 Iontophoresis device |
| 02/06/2002 | EP1177802A1 Wearable, self-contained drug infusion device |
| 02/06/2002 | EP1177793A1 Inhalable medicinal aerosol composition for pain treatment or prevention |
| 02/06/2002 | EP1177788A2 Pharmaceutical composition of fluoxetin in coated dispersible tablets and process for its manufacture |
| 02/06/2002 | EP1177786A1 Stretchable patch |
| 02/06/2002 | EP1177785A2 Growth promoting pharmaceutical implant |
| 02/06/2002 | EP1177217A1 Amphiphile cyclodextrins, preparation and use thereof for solubilising organised systems and incorporating hydrophobic molecules |
| 02/06/2002 | EP1177106A2 Method and device for labeling a two-dimensional polymer adhesive system, especially a transdermal therapeutic system |
| 02/06/2002 | EP1176986A1 Differentiation of monocytes into functional dendritic cells |
| 02/06/2002 | EP1176984A2 Medicament vehicle for the controlled administration of an active agent, produced from lipid matrix-medicament conjugates |
| 02/06/2002 | EP1176983A2 Hyperbranched polymeric micelles for encapsulation and delivery of hydrophobic molecules |
| 02/06/2002 | EP1176982A1 Prucalopride oral solution |
| 02/06/2002 | EP1176972A1 Use of phyllanthus for targeted stimulation of the immune system |
| 02/06/2002 | EP1176971A1 Use of phyllanthus for treating chronically inflammatory and fibrotic processes |
| 02/06/2002 | EP1176962A2 Liposome compositions for improved drug retention |
| 02/06/2002 | EP1176961A2 Nicotine delivery systems |
| 02/06/2002 | EP1176957A1 Method for treating abnormal cell proliferation in the brain |
| 02/06/2002 | EP1176952A2 2r,4s-hydroxyitraconazole isomers |
| 02/06/2002 | EP1176951A1 Drug delivery device |
| 02/06/2002 | EP1176950A1 A method and a device for enclosing application of a coating on a tablet, capsule, pill or the like |
| 02/06/2002 | EP1176949A2 Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same |
| 02/06/2002 | EP1176948A1 Anti-nausea compositions and methods |
| 02/06/2002 | EP1176939A2 Oral care chewing gums and confections |
| 02/06/2002 | EP1176933A1 Topical medicated bioadhesive compositions and methods of use and preparation thereof |